Search Results - "Kanyılmaz, Gül"

Refine Results
  1. 1

    Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors by Kanyılmaz, Gül, Yavuz, Berrin Benli, Aktan, Meryem, Karaağaç, Mustafa, Uyar, Mehmet, Fındık, Sıddıka

    Published in European journal of breast health (01-10-2019)
    “…The clinical feature of breast cancer is very heterogeneous because of the variable prognostic factors impact its behaviour. The aim of study is to find the…”
    Get full text
    Journal Article
  2. 2

    Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient: PSMA Avidity Higher Than FDGs by Şahin, Özlem, Kaya, Buğra, Aydın, Zeynep, Karaağaç, Mustafa, Kanyılmaz, Gül

    Published in Clinical nuclear medicine (01-10-2021)
    “…Abstract We present the 68 Ga-PSMA and 18 F-FDG PET/CT findings comparatively of a 67-year-old prostate cancer and malignant melanoma patient who had COVID-19…”
    Get full text
    Journal Article
  3. 3

    The Significance of Extent of Extracapsular Extension in Patients with T1-2 and N1 Breast Cancer by Kanyılmaz, Gül, Fındık, Sıddıka, Yavuz, Berrin Benli, Aktan, Meryem

    Published in European journal of breast health (01-10-2018)
    “…The prognostic importance of extracapsular extension (ECE) in breast cancer is not yet clear, especially in patients with pathological T1-2 and N1 (pT1-2N1)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prognostic importance of PTEN, EGFR, HER-2, and IGF-1R in gastric cancer patients treated with postoperative chemoradiation by Benli Yavuz, Berrin, Koç, Mehmet, Kozacıoğlu, Sümeyye, Kanyılmaz, Gül, Aktan, Meryem

    Published in Turkish journal of medical sciences (08-08-2019)
    “…This study aimed to describe the prognostic importance of epidermal growth factor (EGFR), phosphatase and tensin homolog (PTEN), human EGF receptor-2 (HER-2),…”
    Get full text
    Journal Article
  6. 6

    The Use of Complementary and Alternative Medicine Among Cancer Patients Treated with Radiotherapy by Kanyilmaz, Gül, Akmansu, Müge, Bora, Hüseyin, Eda Yi̇rmi̇beşoğlu Erkal

    Published in Türk onkoloji dergisi (2022)
    “…OBJECTIVE The purpose of this study was to determine: (1) the prevalence of complementary and alternative medicine (CAM) use (2) the characteristics of CAM…”
    Get full text
    Journal Article
  7. 7

    Radyasyon Onkoloji Servisinde Yatan Hastaların Beslenme Durumunun Değerlendirilmesi by Tugba Yılmaz, Meryem Aktan, Berrin Benli Yavuz, Gül Kanyılmaz, Himmet Durmaz

    “…AmaçRadyasyon onkoloji servisinde yatan kanser hastalarının beslenme durumları net değildir. Kanser hastaları üzerinde yapılan bu kesitsel çalışma, bu hasta…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Prognostic Importance of Ki-67 Labeling Index in Grade II Glial Tumors by Kanyılmaz, Gül

    Published in Türk onkoloji dergisi (2018)
    “…OBJECTIVE To date, several methods have been identified for predicting the prognostic subgroups of grade II gliomas; however, these methods have some…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Investigation of the effect of bolus on skin dose in breast cancer treatment with tomotherapy and LINAC radiotherapy devices by Gul, Osman Vefa, Demir, Hikmettin, Basaran, Hamit, Kanyılmaz, Gul

    “…In postmastectomy radiation therapy (PMRT), it is important that the chest wall skin is included in the target volume and receives an adequate dose. This study…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases by Kanyilmaz, Gul, M.D, Aktan, Meryem, M.D, Koc, Mehmet, M.D, Demir, Hikmettin, Phys, Demir, Lutfi Saltuk, M.D

    “…Abstract This study aims to estimate the incidence of hypothyroidism (HT) and to evaluate the predictors affecting the development of HT after radiotherapy…”
    Get full text
    Journal Article
  14. 14

    Erythema Multiforme Associated With Phenytoin and Cranial RadiationTherapy (EMPACT) Syndrome Associated With Cranial Radiotherapy and Levetiracetam: A Case Report by Yilmaz, Tugba, Yavuz, Berrin B, Kanyilmaz, Gul, Aktan, Meryem, Temiz, Selami A

    Published in Curēus (Palo Alto, CA) (07-02-2022)
    “…Cranial radiotherapy (RT) is an irradiated way to treat patients with brain malignancies. Seizure is the most common symptom. Due to the frequency of seizure…”
    Get full text
    Journal Article
  15. 15

    Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer by Aktan, Meryem, Koc, Mehmet, Kanyilmaz, Gul, Yavuz, Berrin Benli

    Published in Annals of nuclear medicine (01-07-2017)
    “…Purpose Small-cell lung cancer (SCLC) is an aggressive disease, despite an initially favorable response to treatment, and its prognosis is still poor. Multiple…”
    Get full text
    Journal Article
  16. 16

    Onkoloji Hastalarında İştah Arttırıcı Ajanlar ve Özel Diyetler by Kanyilmaz, Gül

    Published in Türk onkoloji dergisi (01-01-2020)
    “…Kanser hastalarında görülen anoreksiyi tedavi edebilmek amacıyla pek çok iştah açıcı ajan geliştirilmiştir. Bu ajanların hepsinin bir miktar yarar sağladığı…”
    Get full text
    Journal Article
  17. 17

    Cutaneous Metastases of the Synchronous Primary Endometrial and Bilateral Ovarian Cancer: An Infrequent Presentation and Literature Review by Findik, Siddika, Koc, Mehmet, Aktan, Meryem, Kanyilmaz, Gul

    Published in Case reports in oncological medicine (01-01-2016)
    “…There are limited data about the cutaneous metastases of gynecological malignancies in the literature. Based on this limited number of studies, cutaneous…”
    Get full text
    Journal Article
  18. 18

    Malnütrisyon Taramasındaki Yöntemler: Hangi Yöntemi Kullanalım? by Akmansu, Müge, Kanyilmaz, Gül

    Published in Türk onkoloji dergisi (01-01-2020)
    “…Nütrisyon riski taraması; farkındalığı arttırmayı, erken tanıyı ve tedaviyi sağlamayı amaçlamaktadır. Onkoloji hastalarında nütrisyonel riski belirlemede…”
    Get full text
    Journal Article
  19. 19

    Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients by Yavuz, Berrin Benli, Kilinc, Fahriye, Kanyilmaz, Gul, Aktan, Meryem

    Published in Journal of neuro-oncology (01-12-2023)
    “…Purpose Pyruvate kinase M2 (PKM2) is a key enzyme that catalyzes the irreversible and final step of glycolysis. It is closely associated with cancer…”
    Get full text
    Journal Article
  20. 20

    Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer by Akmansu, Muge, Buyukberber, Suleyman, Iren, Sevilay, Demirci, Umut, Kanyilmaz, Gul, Coskun, Ugur, Bora, Huseyin

    Published in Case reports in oncology (17-12-2010)
    “…We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly…”
    Get full text
    Journal Article